Concepedia

Kathleen D. Danenberg

KD

Statistics

Publications

142

Citations

13.8K

H-Index

57

Active since

1973

Affiliations

University of Southern California(Current)

USC Norris Comprehensive Cancer Center

University of Cologne

Memorial Sloan Kettering Cancer Center

California Southern University

Kathleen D. Danenberg is an author at University of Southern California specializing in medicine, oncology, and molecular oncology.

Publications per year

1973–2022

142

Publications

142

Colorectal tumors responding to 5-fluorouracil have low gene expression levels of dihydropyrimidine dehydrogenase, thymidylate synthase, and thymidine phosphorylase.

Dennis Salonga, Kathleen D. Danenberg, Martin R. Johnson et al. · PubMed · 2000 · 834 citations

, , +16

Thymidylate synthase gene and protein expression correlate and are associated with response to 5-fluorouracil in human colorectal and gastric tumors.

P. G. Johnston, Heinz-Josef Lenz, Cynthia G. Leichman et al. · PubMed · 1995 · 678 citations

, , +17

Low ERCC1 expression correlates with prolonged survival after cisplatin plus gemcitabine chemotherapy in non-small cell lung cancer.

Reginald V. Lord, Jan Brabender, David R. Gandara et al. · PubMed · 2002 · 671 citations

, , +14

<i>ERCC1</i> and Thymidylate Synthase mRNA Levels Predict Survival for Colorectal Cancer Patients Receiving Combination Oxaliplatin and Fluorouracil Chemotherapy

Yoshinori Shirota, Jan Stoehlmacher, Jan Brabender et al. · Journal of Clinical Oncology · 2001 · 609 citations

, , +16

ERCC1 mRNA levels complement thymidylate synthase mRNA levels in predicting response and survival for gastric cancer patients receiving combination cisplatin and fluorouracil chemotherapy.

R. Metzger, Cynthia G. Leichman, Kathleen D. Danenberg et al. · Journal of Clinical Oncology · 1998 · 510 citations

, , +10

1–5 of 142